Intellia Therapeutics Inc buy Brookline Capital Acquisition Corp.
Start price
03.03.26
/
50%
€12.32
Target price
03.03.27
-
Performance (%)
-1.30%
Price
09:51
€12.16
Summary
This prediction is currently active. With a performance of -1.30%, the BUY prediction by Brookline_Capital_Ac is trending in the wrong direction. This prediction currently runs until 03.03.27. The prediction end date can be changed by Brookline_Capital_Ac at any time. Brookline_Capital_Ac has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 5.548% | 5.548% |
| iShares Core DAX® | 0.231% | -2.413% |
| iShares Nasdaq 100 | 1.663% | -1.658% |
| iShares Nikkei 225® | -0.208% | -2.502% |
| iShares S&P 500 | 1.067% | -1.579% |
Comments by Brookline_Capital_Ac for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NTLA) had its "buy" rating reaffirmed by Brookline Capital Acquisition Corp..
Ratings data for NTLA provided by MarketBeat